A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
The expanding pandemic of coronavirus disease 2019 (COVID-19) requires the development of safe, efficacious and fast-acting vaccines. Several vaccine platforms are being leveraged for a rapid emergency response1. Here we describe the development of a candidate vaccine (YF-S0) for severe acute respir...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
2020
|
Online Erişim: | https://doi.org/10.1038/s41586-020-3035-9 https://www.nature.com/articles/s41586-020-3035-9.pdf |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|